Elvis Pacelat, is VP of Compliance Solutions at AMPLEXOR Life Scienceswww.amplexor.com
The Great Life Sciences Regulatory Redress
Elvis Paćelat outlines some lessons from big pharma as medical device manufacturers succumb to new reporting obligations.
Pharma Must Embrace Digital Transformation
However conservative and heavily regulated the drugs business, it too must transform itself to exploit digital opportunities - if only to ward off disruption, says Elvis Paćelat.